Screener
Cogent Biosciences, Inc. COGT Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342393
FAQ
- What is Cogent Biosciences, Inc.'s interest expense?
- Cogent Biosciences, Inc. (COGT) reported interest expense of $1.22M in Q2 2026.
- How has Cogent Biosciences, Inc.'s interest expense changed year-over-year?
- Cogent Biosciences, Inc.'s interest expense increased by 287.6% year-over-year, from $314K to $1.22M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Cogent Biosciences, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude